Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

More documents

Recommendations

Info

Tsai WC, Pang JH, Hsu CC, Chu NK, Lin MS, Hu CF. Ultrasound stimulation of types I and III collagen expression of tendon cell and upregulation of transforming growth factor beta. J Orth Res 24:1310-6, 2006 Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, Lopez-Otin C, Saarialho-Kere U, Kahari VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 152:1489-99, 1998 Ulrik CS, Backer V. Longitudinal determinants of bronchial responsiveness to inhaled histamine. Chest 113:973-9, 1998 Van Joost T, Heule F, Korstanje M, van der Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis : a multicentre placebo-controlled study. Br J Dermatol 130:376-80, 1994 Veien NK, Busch-Sorensen M, Stausbol-Gron B. Montelukast treatment of moderate-to-severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 53:147-9, 2005 Vickery BP. Skin barrier function in atopic dermatitis. Curr Opin Pediatr 19:89-93, 2007 Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking healthy adults. Scand J Clin Lab Invest 42(suppl):1-20, 1982 Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 70:323-9, 1990 Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y. Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110(1 Pt 1):e2, 2002 Wang T, Li BY, Danielson PD, et al. The immunophilin FKBP12 functions as a common inhibitor of the TGF-beta family type I receptors. Cell 86:435-44, 1996 Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 156:346-51, 2007 Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriquez E, Diaz-Lacava A et al. Loss-offunction variants within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 18:214-9, 2006 Weidinger S, Rodriguez E, Stahl C, Wagenpheil S, Klopp N, Illig T, Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 127:724-6, 2007 Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 25:22-9, 2000 Williams HC, Burney PGJ, Hay RJ, Archer CB, Shipley MJ, Hunter JJA, Bingham EA, Finlay AY, Pembroke AC, Graham-Brown RAC, Atherton DA, Lewis-Jones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, David TJ. The UK Working Party’s diagnostic criteria for atopic dermatitis I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131:383-96, 1994 Williams HC, Strachan DP. The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 139:834-9, 1998 Williams RE. The antibacterial-corticosteroid combination. What is its role in atopic dermatitis? Am J Clin Dermatol 1:211-5, 2000 80
Witt C, Stuckey MS, Woolcock AJ, Dawkins RL. Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol 77:698-702, 1986 Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigenpresenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 107:519-25, 2001 Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 112:667-74, 2003 Wütrich B, Schmid-Grendelmeier P. Definition and diagnosis of intrinsic versus extrinsic atopic dermatitis. In: Bieber T, Leung DYM, editors. Atopic dermatitis. 1st ed. New York: Marcel Dekker Inc.; 2002. p. 1-20. Wütrich B. Serum IgE in atopic dermatitis. Clin Allergy 8:241-8, 1978 Yoshimura-Mishima M, Akamatsu H, Namura S, Horio T. Suppressive effect of ultraviolet (UVB and PUVA) radiation on superantigen production by Staphylococcus aureus. J Dermatol Sc. 19:31-6, 1999 Zhan H, Smith L, Calder V, Buckley R, Lightman S. Clinical and immunological features of atopic keratoconjunctivitis. Int Ophth Clin 43:59-71, 2003 Zonneveld IM, De Rie MA, Beljaards RC, Van-Der-Rhee HJ, Wuite J. Zeegelaar J, et al. The long-term safety and efficacy of cyclosporine in severe refractory atopic dermatitis: a comparison of two dosage regimens. Br J Dermatol 135(suppl):15-20, 1996 Zonneveld IM, Rubins A, Jablonska S, Dobozy A, Ruzicka T, Kind P, Dubertret L, Bos JD. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 134:1101-2, 1998 Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 35:1301-8, 2005 81
Page 1 and 2:
Topical tacrolimus in atopic dermat
Page 3:
To Juha and Veera
Page 6 and 7:
Effects of treatment on skin barrie
Page 8 and 9:
ABBREVIATIONS AD Atopic dermatitis
Page 10 and 11:
and bronchial hyper-responsiveness
Page 12 and 13:
REVIEW OF THE LITERATURE Atopic der
Page 14 and 15:
probably plays a protective role ag
Page 16 and 17:
e induced by IL-2 and bacterial sup
Page 18 and 19:
and has a lower risk for asthma and
Page 20 and 21:
Both asthma and allergic rhinitis i
Page 22 and 23:
early childhood, and is accompanied
Page 24 and 25:
naturally occurring glucocorticoste
Page 26 and 27:
severe atopic dermatitis, hand ecze
Page 28 and 29:
and their complex inhibits activati
Page 30 and 31: extent of topical absorption decrea
Page 32 and 33: of one type of treatment can be bet
Page 34 and 35: liver (Burgeson & Nimni 1992). At l
Page 36 and 37: UVA therapy suppresses collagen syn
Page 38 and 39: AIMS OF THE STUDY Atopic dermatitis
Page 40 and 41: Inclusion criteria Patients with mo
Page 42 and 43: Methods Treatment with tacrolimus o
Page 44 and 45: Respiratory symptoms and findings T
Page 46 and 47: Statistical methods In Studies I, I
Page 48 and 49: Staphylococcus aureus colonization
Page 50 and 51: Table 7. Subject characteristics; o
Page 52 and 53: physician-diagnosed asthma (2.09 vs
Page 54 and 55: In Study V, eight (12%) patients us
Page 56 and 57: Skin collagen synthesis The results
Page 58 and 59: Results of the present uncontrolled
Page 60 and 61: al. 1986, Burrows et al. 1989, Kono
Page 62 and 63: ACKNOWLEDGEMENTS This study was car
Page 64 and 65: REFERENCES Aberer W, Wolff K. Syste
Page 66 and 67: Bousquet J; Jeffery PK, Busse WW, J
Page 68 and 69: Dold S, Wjst M, von Mutius E, Reitm
Page 70 and 71: Haapasaari K. Rossi O. Risteli J. O
Page 72 and 73: Krutmann JT, Morita A. Phototherapy
Page 74 and 75: Nishino K, Fukushima A, Okamoto S,
Page 76 and 77: Quanjer PH, Tammeling GJ, Cotes JE,
Page 78 and 79: Schultz-Larsen F, Diepgen T, Svenso
Page 82: ERRATA Page 36: In Table 2 in the c
show all

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?